Brief: SMS Pharmaceuticals Says VKT Pharma Receives US FDA Approval For Reformulated Ranitidine
26/11/2025 03:02
Nov 26 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS: VKT PHARMA, RECEIVES US FDA APPROVAL FOR ITS REFORMULATED RANITIDINE Source text: ID:nBSEMLvQr Further company coverage: SMSP.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on SMS Pharmaceuticals
See all newsBrief: SMS Pharmaceuticals Ltd Q2 Consol Net Profit INR 398.5 Million
Brief: SMS Pharmaceuticals March-Quarter Consol Net Profit 327.1 Million Rupees
Brief: Sms Pharmaceuticals Says Tax Demand Reduced To 4 Million Rupees From 71.9 Million Rupees
Advisory: Alert incorrectly tagged to SMS Phramaceuticals withdrawn
Brief: SMS Pharmaceuticals Says Completion Of USFDA Inspection At Vizag Manufacturing Facility